Absci (NASDAQ: ABSI)
$3.26
(20.3%)
$0.55
Price as of January 3, 2025, 4:00 p.m. ET
Absci Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Absci Company Info
Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs. The company was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.